Richard E. Lloyd

1.3k total citations
17 papers, 1.0k citations indexed

About

Richard E. Lloyd is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Richard E. Lloyd has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 12 papers in Molecular Biology and 5 papers in Infectious Diseases. Recurrent topics in Richard E. Lloyd's work include Viral Infections and Immunology Research (14 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers) and RNA and protein synthesis mechanisms (6 papers). Richard E. Lloyd is often cited by papers focused on Viral Infections and Immunology Research (14 papers), Viral Infectious Diseases and Gene Expression in Insects (7 papers) and RNA and protein synthesis mechanisms (6 papers). Richard E. Lloyd collaborates with scholars based in United States. Richard E. Lloyd's co-authors include Marvin J. Grubman, E Ehrenfeld, Ellie Ehrenfeld, Vikram N. Vakharia, Michael Bovée, D Etchison, Elizabeth E. Wyckoff, Haruka Toyoda, Marilyn I. Steele and Eckard Wimmer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Hepatology.

In The Last Decade

Richard E. Lloyd

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard E. Lloyd United States 16 770 499 270 247 143 17 1.0k
Kate Hole Canada 16 235 0.3× 294 0.6× 103 0.4× 331 1.3× 47 0.3× 28 849
Dino Feigelstock United States 12 194 0.3× 177 0.4× 153 0.6× 138 0.6× 38 0.3× 15 600
B.E. Enger-Valk Netherlands 11 189 0.2× 274 0.5× 106 0.4× 78 0.3× 96 0.7× 16 566
Cecilia Tami United States 12 262 0.3× 222 0.4× 90 0.3× 270 1.1× 59 0.4× 15 675
A Hamel Canada 14 263 0.3× 288 0.6× 655 2.4× 87 0.4× 690 4.8× 14 1.4k
Gema Gómez‐Mariano Spain 14 132 0.2× 289 0.6× 146 0.5× 122 0.5× 208 1.5× 28 658
Bryan T. Butman United States 16 171 0.2× 263 0.5× 126 0.5× 143 0.6× 134 0.9× 26 913
Elena Cherkasova United States 13 360 0.5× 361 0.7× 339 1.3× 36 0.1× 88 0.6× 30 950
Fredy Siegrist Switzerland 6 273 0.4× 433 0.9× 258 1.0× 59 0.2× 82 0.6× 7 828
Oliver Bauhofer Germany 11 249 0.3× 126 0.3× 177 0.7× 401 1.6× 65 0.5× 11 734

Countries citing papers authored by Richard E. Lloyd

Since Specialization
Citations

This map shows the geographic impact of Richard E. Lloyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Lloyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Lloyd more than expected).

Fields of papers citing papers by Richard E. Lloyd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Lloyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Lloyd. The network helps show where Richard E. Lloyd may publish in the future.

Co-authorship network of co-authors of Richard E. Lloyd

This figure shows the co-authorship network connecting the top 25 collaborators of Richard E. Lloyd. A scholar is included among the top collaborators of Richard E. Lloyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard E. Lloyd. Richard E. Lloyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Glaspy, John A., Saroj Vadhan‐Raj, Ravi Patel, et al.. (2006). Randomized Comparison of Every-2-Week Darbepoetin Alfa and Weekly Epoetin Alfa for the Treatment of Chemotherapy-Induced Anemia: The 20030125 Study Group Trial. Journal of Clinical Oncology. 24(15). 2290–2297. 59 indexed citations
2.
Bovée, Michael, Barry J. Lamphear, Robert E. Rhoads, & Richard E. Lloyd. (1998). Direct Cleavage of eIF4G by Poliovirus 2A Protease Is Inefficientin Vitro. Virology. 245(2). 241–249. 43 indexed citations
3.
Bovée, Michael, Wilfred E. Marissen, Miguel Zamora, & Richard E. Lloyd. (1998). The Predominant eIF4G-Specific Cleavage Activity in Poliovirus-Infected HeLa Cells Is Distinct from 2A Protease. Virology. 245(2). 229–240. 44 indexed citations
4.
Barrett, D J, et al.. (1996). The outcome of poliovirus infections in K562 cells is cytolytic rather than persistent after hemin-induced differentiation. Journal of Virology. 70(8). 5525–5532. 16 indexed citations
5.
Murphy, J W, et al.. (1995). K562 Cell Strains Differ in Their Response to Poliovirus Infection. Virology. 213(1). 7–18. 14 indexed citations
7.
Yu, ShunJiang, et al.. (1995). Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity. Journal of Virology. 69(1). 247–252. 40 indexed citations
8.
Lloyd, Richard E. & Michael Bovée. (1993). Persistent Infection of Human Erythroblastoid Cells by Poliovirus. Virology. 194(1). 200–209. 43 indexed citations
9.
Lloyd, Richard E., et al.. (1992). Characterization of the roles of conserved cysteine and histidine residues in poliovirus 2A protease. Virology. 186(2). 725–735. 44 indexed citations
10.
Wyckoff, Elizabeth E., Richard E. Lloyd, & E Ehrenfeld. (1992). Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity. Journal of Virology. 66(5). 2943–2951. 50 indexed citations
11.
Lloyd, Richard E., et al.. (1991). Identification of essential amino acid residues in the functional activity of poliovirus 2A protease. Virology. 182(2). 615–625. 75 indexed citations
12.
Vakharia, Vikram N., et al.. (1988). Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. Journal of Virology. 62(11). 4407–4409. 264 indexed citations
13.
Lloyd, Richard E., Marvin J. Grubman, & Ellie Ehrenfeld. (1988). Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing. Journal of Virology. 62(11). 4216–4223. 118 indexed citations
15.
Lloyd, Richard E., Haruka Toyoda, D Etchison, Eckard Wimmer, & Ellie Ehrenfeld. (1986). Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology. 150(1). 299–303. 68 indexed citations
16.
Lloyd, Richard E., D Etchison, & E Ehrenfeld. (1985). Poliovirus protease does not mediate cleavage of the 220,000-Da component of the cap binding protein complex.. Proceedings of the National Academy of Sciences. 82(9). 2723–2727. 32 indexed citations
17.
Lloyd, Richard E., Stephen E. Jones, & Sydney E. Salmon. (1979). Comparative trial of low-dose adriamycin plus cyclophosphamide with or without additive hormonal therapy in advanced breast cancer. Cancer. 43(1). 60–65. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026